Belladonna alkaloids, butalbital, caffeine, ergotamine
Sold as Cafergot-pb
Every registration of this product has been cancelled.
Combination product
This product contains more than one active ingredient, so it has no single molecular structure.
Background
Registration
- Applicants
- 1
- Registrations
- 1
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Pharmaco Distribution (Pty) LtdCancelled | Cafergot-pb | Not stated | H0582 | Not determined | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Cafergot-pb EACH SUPPOSITORY CONTAINS BELLADONNA ALKALOIDS A 0,000250 g BUTALBITAL A 0,1 g CAFFEINE A 0,1 g ERGOTAMINE TARTRATE A 0,0020 g | Not listed | H0582 | Cancelled | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S6: Butalbital
Consolidated Schedules 06 July 2026, line 10101
S3: Caffeine
- when intended for injection.
Consolidated Schedules 06 July 2026, line 3256
S2: Belladonna alkaloids
- except when intended for topical application.
Consolidated Schedules 06 July 2026, line 1656
S2: Ergotamine
Consolidated Schedules 06 July 2026, line 1919
S1: Belladonna alkaloids
- when specifically intended for topical application.
Consolidated Schedules 06 July 2026, line 152
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.